Genetically Modified Mice for Studying TNAP Function

Area of Science:

• Biochemistry
• Genetics
• Molecular Biology

Background:

• Genetically modified mice are crucial for studying gene function and modeling human diseases.
• Tissue-nonspecific alkaline phosphatase (TNAP) plays a vital role in biological processes.
• Dysfunction of TNAP is associated with hypophosphatasia, a metabolic bone disorder.

Purpose of the Study:

• To describe knockout and transgenic mouse models of TNAP.
• To investigate the function of TNAP using these mouse models.
• To explore potential therapeutic strategies for TNAP deficiency.

Main Methods:

• Generation and characterization of conventional, conditional, and ENU-mutagenized TNAP knockout mouse lines.
• Enzyme replacement therapy using recombinant human TNAP.
• Analysis of double knockout mice with related enzymes.
• Biochemical assays to identify TNAP substrates and assess protein phosphorylation.

Main Results:

• Conventional TNAP knockout mice display lethal epilepsy and impaired bone mineralization, resembling infantile hypophosphatasia.
• Recombinant human TNAP administration rescues the lethal phenotype and improves bone mineralization.
• Pyridoxal phosphate, inorganic pyrophosphate, and osteopontin identified as natural substrates of TNAP.
• Conditional knockout and ENU mutant mice model milder forms of hypophosphatasia, relevant to adult disease.

Conclusions:

• TNAP knockout mice are valuable models for studying hypophosphatasia and TNAP function.
• Enzyme replacement therapy with TNAP is a viable treatment for TNAP deficiency disorders.
• Identification of TNAP substrates deepens understanding of its role in bone mineralization and neurological function.